CACNA1A

Clinical trials for CACNA1A explained in plain language.

Never miss a new study

Get alerted when new CACNA1A trials appear

Sign up with your email to follow new studies for CACNA1A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a simple amino acid ease rare brain disorders?

Symptom relief Not yet recruiting

This study tests a drug called N-acetyl-L-leucine for people aged 4 and older with CACNA1A gene disorders, which can cause coordination problems, dizziness, and migraines. About 60 participants will receive either the drug or a placebo, then switch, to see if it improves movement…

Matched conditions: CACNA1A

Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Symptom relief

Last updated Jun 27, 2026 13:03 UTC

CACNA1A

Get alerted when new CACNA1A trials appear

Could a simple amino acid ease rare brain disorders?